Vicki L Sato is Director of Denali Therapeutics Inc.. Currently has a direct ownership of 116,369 shares of DNLI, which is worth approximately $2.16 Million. The most recent transaction as insider was on May 15, 2024, when has been sold 1,674 shares (Common Stock) at a price of $20.39 per share, resulting in proceeds of $34,132. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 116K
4.12% 3M change
14.67% 12M change
Total Value Held $2.16 Million

VICKI L SATO Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 15 2024
SELL
Open market or private sale
$34,132 $20.39 p/Share
1,674 Reduced 1.42%
116,369 Common Stock
Apr 15 2024
SELL
Open market or private sale
$30,471 $18.29 p/Share
1,666 Reduced 1.39%
118,043 Common Stock
Mar 15 2024
SELL
Open market or private sale
$33,486 $20.1 p/Share
1,666 Reduced 1.37%
119,709 Common Stock
Feb 15 2024
SELL
Open market or private sale
$30,604 $18.37 p/Share
1,666 Reduced 1.35%
121,375 Common Stock
Jan 16 2024
SELL
Open market or private sale
$30,687 $18.42 p/Share
1,666 Reduced 1.34%
123,041 Common Stock
Dec 15 2023
SELL
Open market or private sale
$38,967 $23.39 p/Share
1,666 Reduced 1.32%
124,707 Common Stock
Nov 15 2023
SELL
Open market or private sale
$31,870 $19.13 p/Share
1,666 Reduced 1.3%
126,373 Common Stock
Oct 16 2023
SELL
Open market or private sale
$34,419 $20.66 p/Share
1,666 Reduced 1.28%
128,039 Common Stock
Sep 15 2023
SELL
Open market or private sale
$39,950 $23.98 p/Share
1,666 Reduced 1.27%
129,705 Common Stock
Aug 15 2023
SELL
Open market or private sale
$40,483 $24.3 p/Share
1,666 Reduced 1.25%
131,371 Common Stock
Jul 17 2023
SELL
Open market or private sale
$49,313 $29.6 p/Share
1,666 Reduced 1.24%
133,037 Common Stock
Jun 28 2023
SELL
Open market or private sale
$49,580 $29.76 p/Share
1,666 Reduced 1.22%
134,703 Common Stock
Jun 01 2023
BUY
Grant, award, or other acquisition
-
4,216 Added 3.0%
136,369 Common Stock
Jun 02 2022
BUY
Grant, award, or other acquisition
-
5,986 Added 4.04%
142,149 Common Stock
Nov 10 2021
SELL
Open market or private sale
$88,131 $52.9 p/Share
1,666 Reduced 1.3%
126,167 Common Stock
Nov 01 2021
SELL
Open market or private sale
$83,383 $50.05 p/Share
1,666 Reduced 1.29%
127,833 Common Stock
Sep 15 2021
SELL
Open market or private sale
$89,131 $53.5 p/Share
1,666 Reduced 1.27%
129,499 Common Stock
Aug 18 2021
SELL
Open market or private sale
$86,116 $51.69 p/Share
1,666 Reduced 1.25%
131,165 Common Stock
Jul 21 2021
SELL
Open market or private sale
$108,440 $65.09 p/Share
1,666 Reduced 1.24%
132,831 Common Stock
Jun 23 2021
SELL
Open market or private sale
$117,703 $70.65 p/Share
1,666 Reduced 1.22%
134,497 Common Stock
Jun 02 2021
BUY
Grant, award, or other acquisition
-
2,074 Added 1.5%
136,163 Common Stock
May 26 2021
SELL
Open market or private sale
$109,673 $65.83 p/Share
1,666 Reduced 1.23%
134,089 Common Stock
Apr 28 2021
SELL
Open market or private sale
$103,175 $61.93 p/Share
1,666 Reduced 1.21%
135,755 Common Stock
Mar 31 2021
SELL
Open market or private sale
$93,646 $56.21 p/Share
1,666 Reduced 1.2%
137,421 Common Stock
Mar 03 2021
SELL
Open market or private sale
$103,109 $61.89 p/Share
1,666 Reduced 1.18%
139,087 Common Stock

Also insider at

BMY
BRISTOL MYERS SQUIBB CO Healthcare
VIR
Vir Biotechnology, Inc. Healthcare
AKUS
Akouos, Inc. Healthcare
ALLO
Allogene Therapeutics, Inc. Healthcare
VLS

Vicki L Sato

Director
New York, NY

Track Institutional and Insider Activities on DNLI

Follow Denali Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNLI shares.

Notify only if

Insider Trading

Get notified when an Denali Therapeutics Inc. insider buys or sells DNLI shares.

Notify only if

News

Receive news related to Denali Therapeutics Inc.

Track Activities on DNLI